Patents by Inventor Rui Zou

Rui Zou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MOBILE CARDIAC HEALTH MONITORING
    Publication number: 20140073969
    Abstract: Techniques for mobile cardiac health monitoring are disclosed. In some embodiments, a system for mobile cardiac health monitoring includes a mobile device that includes a processor configured to receive a first set of data from an optical sensor; receive a second set of data from an electrical sensor; and perform a plurality of cardiac health measurements using the first set of data from the optical sensor and the second set of data from the electrical sensor.
    Type: Application
    Filed: August 22, 2013
    Publication date: March 13, 2014
    Inventors: Rui Zou, An Luo, Cheng-I Chuang
  • Targeted replacement of a gene without endogenous and selectable residual sequences
    Publication number: 20030167489
    Abstract: Transgenic mice that produce high levels of humanized antibodies are described. Targeted gene replacement exchanges constant regions of the mouse immunoglobulin heavy and light chain genes with human genes, either through conventional gene targeting, or by use of the bacteriophage-derived Cre-loxP recombination system. The transgenic animals undergo antibody affinity maturation, and a class switch from the native immunoglobulin to the humanized form.
    Type: Application
    Filed: October 15, 2002
    Publication date: September 4, 2003
    Inventors: Klaus Rajewsky, Yong-Rui Zou
  • Targeted replacement of an immunoglobulin gene without endogenous and selectable residual sequences in mice
    Patent number: 6570061
    Abstract: Transgenic mice that produce high levels of humanized antibodies are described. Targeted gene replacement exchanges constant regions of the mouse immunoglobulin heavy and light chain genes with human genes, either through conventional gene targeting, or by use of the bacteriophage-derived Cre-loxP recombination system. The transgenic animals undergo antibody affinity maturation, and a class switch from the native immunoglobulin to the humanized form.
    Type: Grant
    Filed: February 23, 1995
    Date of Patent: May 27, 2003
    Inventors: Klaus Rajewsky, Yong-Rui Zou
  • Charger
    Patent number: D804410
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: December 5, 2017
    Assignee: EMOMO TECHNOLOGY CO., LTD
    Inventors: Wenji Tang, Huiyao An, Rui Zou, Keyun Zhang, Zhigang Wang, Yushu Zhao
  • Charger
    Patent number: D805472
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: December 19, 2017
    Assignee: EMOMO TECHNOLOGY CO., LTD
    Inventors: Wenji Tang, Zhigang Wang, Keyun Zhang, Rui Zou